Boyle Scott N bought CCCC
February 14, 2024 · Form 4 insider transaction
Boyle Scott N bought 122,800 shares of C4 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
122,800
Price
$0.00
Total value
N/A
InsiderBoyle Scott N
Role—
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 14, 2024
Filing dateFebruary 15, 2024
Shares owned after122,800
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 14, 2024.